Management of High-Risk Acute Coronary Syndrome
Immediate Recognition and Medical Management
- The European Society of Cardiology recommends immediate dual antiplatelet therapy with aspirin 162-325 mg loading dose plus a P2Y12 inhibitor, anticoagulation, and urgent coronary angiography within 2 hours for patients with high-risk acute coronary syndrome, likely left main or severe three-vessel disease 1, 2
- The combination of ST depression in V3-V6 with ST elevation in aVR is a high-risk marker for left main or proximal left anterior descending coronary artery disease, which carries significant mortality risk and requires immediate invasive management 1, 2
- The American College of Cardiology recommends aspirin 162-325 mg loading dose (chewable preferred for faster absorption) immediately, and adding a P2Y12 inhibitor, such as ticagrelor 180 mg loading dose, for all moderate-to-high risk patients 1, 4
- The European Heart Society recommends anticoagulation with enoxaparin (1 mg/kg subcutaneously every 12 hours, adjusted for renal function) or unfractionated heparin (60-70 units/kg bolus, maximum 5000 units, followed by infusion of 12-15 units/kg/hour targeting aPTT 1.5-2.0 times control) immediately 1, 2, 4
Urgent Invasive Strategy
- The European Society of Cardiology recommends coronary angiography within 2 hours for patients with very-high-risk features, such as recurrent or ongoing chest pain, dynamic ST-segment changes, and high-risk ECG pattern (ST elevation in aVR with diffuse ST depression) 1, 2
- The American College of Cardiology recommends against delaying angiography to 24-72 hours for patients with ST elevation in aVR with diffuse ST depression, as it indicates very high risk requiring immediate (<2 hour) catheterization 1, 2